Paul Peter Tak, CEO: Candel Therapeutics CADL Planned sale · Filed 25/03/18

Trade details

Type: Planned sale notice
Stock: Candel Therapeutics CADL
Person: Paul Peter TakCEO
Planned sale date: 25/03/18
Filed: 25/03/18

More to sell after $330.8K in 3 months

Candel Therapeutics trades, last 26 weeks

What else happened in Candel Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/16~25/04/17

Paul Peter Tak's recent trades

Paul Peter TakCEO
Planned sale10b5-1 planCandel Therapeutics
Planned sale10b5-1 plan
Candel Therapeutics
CADL
$3.4M
280,245 sh
$3.4M
Filed 09/10
Traded 09/10
Paul Peter TakCEO
Sell10b5-1 planCandel Therapeutics
Sell10b5-1 plan
Candel Therapeutics
CADL
$226K
25,772 sh
$226K
Filed 25/03/20
Traded 25/03/18
Paul Peter TakCEO
Sell10b5-1 planCandel Therapeutics
Sell10b5-1 plan
Candel Therapeutics
CADL
$3,600
400 sh
$3,600
Filed 25/03/20
Traded 25/03/19
Paul Peter TakCEO
SellCandel Therapeutics
Sell
Candel Therapeutics
CADL
$156.9K
21,704 sh
$156.9K
Filed 25/01/17
Traded 25/01/15
Paul Peter TakOfficer, Director
Planned saleCandel Therapeutics
Planned sale
Candel Therapeutics
CADL
$156.6K
19,970 sh
$156.6K
Filed 25/01/15
Traded 25/01/15